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Abstract:Nanotechnology has taken great strides in the field of medicine with improved 
drug delivery systems. The application of nanoparticles in cancer detection and treatment 
has been prominent in recent years wherein unique properties can be utilized for detection 
of site specific tumors. The main objective of this review is to give an update on the 
available techniques and briefly describe the nano-medicines developed so far for an 
effective treatment. Conventional techniques face the problem of toxicity resulting from the 
administered drug. In addition to this, most of the techniques available detect cancer only 
after metastasis which hampers the effectiveness of the anti-cancer drug.  Through the 
application of nanotechnology techniques, active cancer cells can be differentiated and 
treated without harming the healthy cells. This review discusses the use of nanoparticles 
like quantum dots and fullerenes for detection of cancer cells by acting as imaging agents. 
These are crucial for identifying the affected cells and tissues for effective measurement. 
Liposomes and dendrimers are used in treatment through development of advanced drug 
delivery systems. Some other nanoparticles like carbon nanotubes and magnetic 
nanoparticles have extended application in both imaging and treatment. Due to its wide 
ranging properties and diverse applications, the nanoparticles developed so far and 
nanotechnology as a whole has a huge potential in cancer treatment. 
Keywords:Cancer, Nanotechnology, Nano medicine, Nanoparticle. 
 
1. Introduction 
Cancer is caused due to the uncontrolled division of 
abnormal cells. One of the most common features is 
the potential to spread to other parts of the body. It 
has the capacity to destroy healthy cells and tissues 
which has proved to be fatal over the years. Normal 
cells are transformed into tumor cells when genetic 
factors of a person interact with some external agents 
like physical, chemical and biological carcinogens 
which are a multistage process [1]. In fact, it remains 
as one of the most common cause of death. Almost 
90-95% cases on cancer are induced by 
environmental factors, for example, excessive 
exposure to UV radiation in case of skin cancer. The 
remaining 5-10% is due to inherited genetics [2]. 
There are about 100 different cancer types out of 
which the common ones are lung, stomach, liver, 
esophagus, colorectal, breast, melanoma and cervical 
cancer. According to the GLOBOCAN and WHO 
statistics, in 2012, there were 14.1 million new cancer 
cases, 8.2 million cancer deaths and 32.6 million 
people living with cancer (within five years of 
diagnosis). Worldwide around 57% of new cancer 
cases, 65% of cancer deaths and 48% people are 
living with cancer in the span of five years [3]. The 
burden of cancer will increase to 23.6 million new 
cases each year by 2030. This represents an increase 
of 68% compared with 2012 [4]. The conventional 
methods which are still in practice include surgery, 
chemotherapy, radio therapy and targeted therapy. 
Surgery and radio therapy allows the removal of 
cancer cells only to that specific targeted area and 
chemotherapy that allows the drug to flow through 
the bloodstream or can be delivered directly to the 
specific area. Targeted therapy is a newer technique 
that allows the removal of cancer cells more precisely 
and thus leading to less damage to normal cells. The 
effectiveness of treatment can be judged on the basis 
of drug’s ability to target and kill cancer cells while 
leaving healthy cells intact. In fact, in designing anti-
cancer agents, the most important feature should be 
differentiation of healthy and affected cells. Another 
factor to be taken into consideration is the bio-
compatibility of the drug such that the side effects are 
reduced. The current available techniques are lacking 
behind when it comes the aforementioned factors. 
Newer techniques like nanotechnology are currently 
in research since it provides a promising approach 
when it comes to cancer cell selectivity and reduced 
side effects.  
Nanotechnology is a science which deals with 
processes that occur at molecular end; supra 
molecular level resulting in nanoparticles of unique 
properties such as increased solubility and bio 
compatibility. It has wide ranging applications suchas 
bio-sensors. Due to increased surface modification 
properties, it can be used in targeted delivery in case 
of cancer detection. Nano-systems have an edge over 
conventional methods when it comes to drug delivery 
and toxicity. Some of the nanoparticles used for 
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cancer detection and treatment include liposomes, 
dendrimers, fullerene, quantum dots, magnetic 
nanoparticles, gold nanoparticles, nano-wires, nano-
shells and carbon-nanotubes. Nanotechnology in 
conjunction with medicine provides an important 
platform where nano-carriers can be manipulated as 
well as used for multifunctional properties. It is one 
of the most promising approaches in detection and 
treatment of cancer. 
2. Background on Targeted Drug 
Delivery 
Figure 1: Targeted drug delivery 
 
Targeted drug delivery is a process in which the 
required drug is encapsulated by a nanoparticle. The 
specific receptors on cell surface react with the drug 
encapsulated by the nano-carriers or nanoparticles. 
The effective drug delivery systems must meet 
certain criteria. The nanoparticles must have high 
loading capacity for selected drug, high response to 
stimuli, high bioavailability and stability. In addition 
to this, specific targeting, long circulation and 
intracellular delivery are some of the features. The 
nano-systems can identify biomarkers and detect 
tumor cells [5, 6]. In this regard, nanotechnology 
protects drug from degradation before they reach 
their target and enhances absorption of drugs into 
tumors [7]. Another conclusion we can draw is that 
using nanoparticles, the drug release rates can be 
precisely controlled while reducing the side-effects 
[6]. The nanoparticles which are used as drug 
delivery vehicles are generally <100nm in size and 
they consist of different bio-degradable materials 
such as natural or synthetic polymers, metals or lipids 
[8] along with their applications. Two of the nano-
formulated drugs available in the market today are 
Abraxine and Doxil. Abraxine is a human albumin 
based nano-formulated drug with a size of around 
100nm. It is also known as ABI-007 or nanoparticle 
albumin bound [nab]-Paclitaxel [PTX]. To reduce 
side effects, albumin has been used to conjugate PTX 
with Cremophor. Doxil is the formulation of 
doxorubicin in nano-liposome and has shown 
significant improvements over free doxorubicin[10, 
11]. In some other clinical trials, various 
combinations of drugs have been implemented. In 
[9], doxorubicin and docetaxel has been reported to 
be used in-vitro for detection and treatment of 
prostate cancer and various other types. Similarly, for 
treatment of lung carcinoma and melanoma, a 
combination of combretastatin and doxorubicin has 
been used in-vivo. 
 
Figure 2: Nano formulated dugs and their 
applications [9, 10, 11]
 
3. Nanotechnology in Cancer Detection 
The detection of cancer at an early stage is one of the 
factors to be considered for effective cancer 
treatment. With advancements in technologies, newer 
techniques like optical based imaging have been used 
for cancer detection. The use of nanoparticles for 
image contrast and enhancement has enabled 
improvements in cancer imaging. Some of the 
nanoparticles listed below have proven to be useful 
tools in cancer detection. 
3.1 Quantum Dots 
Quantum dots are nano-crystals ranging from 2-10nm 
which have extensively attracted great interest in the 
field of biology and medicine because of its unique 
optical and electrical properties. Quantum dots have a 
distinct advantage over conventional biomarkers 
because of their high photo stability and size tunable 
excitation [14]. The use of quantum dots 
hasbeenextended in the NIR wavelength range as an 
imaging probe. The main advantage of the technique 
is that it increases the depth of tissue penetration 
which will lead to more accurate detection in-vivo 
[10, 15].  Some of the materials best suited in 
building up quantum dots are cadmium sulphide and  
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Figure 3: Bio-imaging using Quantum-dots 
 
cadmium selenide. However, based on factors like 
toxicity and bio-compatibility, Zinc Sulfide is 
preferred [16].  Applications of quantum dots include 
in-vivo and in-vitro imaging, live cell imaging and 
single molecule tracking. It is used for the detection 
of lung cancer, breast cancer, prostate cancer and 
pancreatic cancer, detection of primary tumor in 
vitro, prostate cancer, targeting and imaging 
melanoma and also detection of thyroid carcinoma 
antigen [15, 16, 17]. Some of the applications shown 
in figure 3 include protein detection in cancer cells 
and tumour detection in mice. 
 
3.2 Carbon Nanotubes 
CNT belong to the family of fullerenes and are 
formed of coaxial graphite sheets (<100 nm) rolled 
up into cylinders. Structurally there are two types: 
single-walled carbon nanotubes (SWCNTs) and 
multi-walled carbon nanotubes (MWCNTs). It 
possesses properties such as high aspect ratio, ultra-
light weight, tremendous strength and high thermal 
conductivity. However, in the field of cancer, 
diagnostic and therapeutic, three main properties 
have been exploited i.e., small size, high surface area 
to volume ratio and their ability to contain chemicals 
[18, 19, 20]. The surface of carbon nanotubes can be 
modified with proteins for cellular uptake which are 
then heated up upon absorbing near-IR light wave. 
When exposed to near-IR light, carbon nanotubes 
quickly release excess energy as heat (~70ºC) which 
can kill cancerous cells[21]. Due to their unique 
properties, they have wide ranging applications in 
cancer diagnosis and therapy. Some of the notable 
applications in cancer diagnosis are molecular 
imaging with single-walled carbon nanotubes and 
cancer biomarker detection. It is also used for drug 
delivery and thermal therapy. CNTs have proposed as 
a promising tool for detecting cancer at early stages 
with high sensitivity, selectivity and low detection  
 
limit [18]. Figure 4 shows the Schematics of a 
functionalised single-walled carbon nanotube with 
Cyanine Dye #3Labelled DNA (Cy3-DNA). 
Figure 4: Targeted single-walled carbon 
nanotubes[12] 
3.3 Metalic nanoparticles 
Metallic nanoparticles have attractive properties like 
high surface Plasmon resonance, optical properties 
which can be tuned from visible to infra-red range. 
They possess large surface energy and have the 
ability to adsorb small molecules. Gold, silver and 
platinum are some of the metallic nanoparticles that 
have been used for cancer diagnosis and therapy.  
Gold nanoparticles have already been used as a 
vehicle for the delivery of anti-cancer drugs such as 
paclitaxel. The properties of gold nanoparticles 
including small size, bio-compatibility, high atomic 
number and ability to bind targeting agents gives an 
advantage over other nanoparticles to be used as 
contrast agents. The formation of bubble around the 
overheated gold nanoparticles in liquid environment 
followed by generation of acoustic and shock waves 
protein inactivation has become a profound area of 
research. Gold has also been used together with 
magnetic materials to improve the photo thermal 
effect to accelerate the death of cancer cells [21, 22, 
23, 24]. Platinum nanoparticles act as prominent 
radiation sensitizers in radiotherapy cancer treatment 
showed improvements in biological efficiency of 
radiations, leading to amplified damage in DNS from 
tumor cells when compared to metal atoms 
[22]
. Silver 
nanoparticles can be used for both active and passive 
targeting of drugs. It has been emerged as an 
attractive candidate for delivery of various small drug 
molecules or large biomolecules like proteins, DNA 
or RNA. An attempt to use silver nanoparticles as an 
anti-cancer agent has been proven to be successful. 
Limitations like toxicity and larger nanoparticles 
involves in targeting of silver nanoparticles to cancer 
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cells [25]. Figure 5 shows the gold nanoparticles used 
for detecting cancer cells. 
 
Figure 5: Gold nanoparticles detecting cancer cells 
[24] 
4. Nanotechnology in cancer treatment 
The use of nanotechnology in cancer treatment offers 
some exciting possibilities and newer platforms 
which includes minimal damage to healthy tissue and 
organs and elimination of cancer cells before they 
form tumor. Some of the nanoparticles used for 
cancer treatment are liposomes, dendrimers and 
magnetic nanoparticles. 
4.1 Liposomes 
Liposomes are small artificial vesicles which are 
incredibly biodegradable. The confinement and 
protection of the drug enclosed is done by the fatty 
layer on the liposomes. In this way, efficacy is 
improved keeping toxicity to healthy cells 
minimized. Their size ranges from 25nm to 10µm 
depending on the preparation method. Sizes which 
are less than 400nm can rapidly penetrate tumour  





sites from the blood stream by the endothelial wall in 
healthy tissue vasculature.  Because of their unique 
structure, liposomes are considered as a versatile 
platform for combination drug delivery because they 
can simultaneously load hydrophilic drugs in their 
aqueous core and hydrophobic drugs in their lipid bi-
layered membrane. Some of the liposomal products 
used currently for cancer treatment include Doxil, 
DaunoXome®, DepoCyt®  and ONCO-TCS, which 
are liposomal formulations of doxorubicin, 
daunorubicin, cytarabineand vincristine, respectively 
[12, 21, 26]. Figure 6 shows the cross section of a 
liposome used for drug delivery. 






Dendrimers generally possess multiple branches 
which is advantageous when it comes to 
multifunctional applications. In cancer, treatment and 
drug delivery systems can be used to carry multiple 
drugs at the same time to tumor site improving 
efficiency and reduces the time constraint. It has 
gained interest because of their cylindrical structures 
which often comes with unique properties. Sensitivity 
of imaging can be improved since they can be 
targeted to a single site and the unique architecture 
enables for multivalent attachment of imaging 
probes, as well as targeting moieties. In this way, it 
improves the therapeutic index of cytotoxic drugs by 
direct delivery to cancer cells and also offers drug 
resistance in tumor cells [9, 12, 26]. Figure 7 shows 
the dendrimers carrying multiple chemotherapy drugs 
for treating cancer. 
4.3 Magnetic nanoparticles 
Magnetic nanoparticles have been used in bio-
medical field including cancer treatment. One of the 
most widely used nanoparticle of this kind are the 
super magnetic iron oxide nanoparticles (SPIONs). 
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One of the distinguishing features of SPIONs for 
drug deliver is their applicability for both magnetic 
properties and anti-body attachment which will 
improve targeting capability. Magnetic iron oxide 
particles offer a huge advantage over the other 
particles since they are highly bio-compatible [6, 23]. 
Magnetic nanoparticles are currently in development 
as a promising new type of cancer treatment which 
selectively heat tumor cells to temperatures high 
enough to kill cancer cells without harming normal 
ones. This destroys tumors and leads to the activation 
of immune system to attack other cells throughout the 
body. In fact, the heat produced can kill the cancer 
cells and releases the drug from the nanoparticles 
directly inside the cancer cells [27]. Magnetic-
radiated hyperthermia can be used for local tumor 
treatments. It also ramps up the immune system to 
find and destroy distant cells. This is because cancer 
cells produce more heat shock proteins (HSPs). 
When cancer cells are heated to high temperatures, 
they produce HSPs in high quantities which in turn 
binds to antigens (molecules or proteins that trigger 
and immune response). When some cells are 
destroyed by the heat, their HSPs and antigens are 
released into the body  that attracts cells from the 
immune system which then interact with the HSP-
antigen complex and used them to hunt down other 




5. Limitations and Future Prospects 
One of the most prominent challenges is that of 
clinical translation. There are only six FDA approved 
nano-medicines: Adcetris (Brentuximabvedotin) and 
Kadcyla (Trastuzumabemtansine) are antibody-drug 
conjugates, Doxil (liposomal doxorubicin), Abraxane 
(human serum albumin non-specifically bound to 
paclitaxel), Marqibo (liposomal vincristin), and 
DaunoXome (liposomal daunorubicin).One of the 
challenges with these medicines is the lack of 
complete elimination from the body. Currently 
available techniques have to undergo extensive 
research to check the accuracy and their relevancy to 
the real patients. Some other challenges can include 
limited knowledge about the cancer physiology and 
poor functionalization of the available nano-
medicines [29]. The bio-safety of the nanoparticle is 
another roadblock because of the host’s 
overwhelming response to the invading Nanoparticles 
[30].Although nano-medicines impose no threats 
immediately, long term side effects are yet to be 
tested. Another limitation is the cost of the 
nanomedicines. Despite all of these limitations, the 
use of nanotechnology in detection and in drug 
delivery systems has grown exponentially over the 
years. The combination of the conventional methods 
with the nano-medicines provides a promising way 
where nanotechnology can be employed in the 
treatment of Cancer. Multifunctional nanoparticles 
provide a new way of embedding various functions 
into one system to detect and kill cancer cells 
simultaneously. Better and stable systems for 
controlled release of drugs have to be designed. A 
better understanding of the properties of the carrier 
and mechanism of loading can provide a 
technological breakthrough. In future, the chemicals 
and materials used for making the nano-materials 
should be formulated for its activity and toxicity. 
Thus, the outcome for patients with metastatic cancer 
will greatly improve if nanoparticles are developed 
with the right therapies in the right direction. 
6. Conclusion 
Cancer being an uncontrolled disease leads a patient 
to death. Various methods and protocols such as 
chemotherapy, radiology and surgery have been used 
which has many side effects that make patients feel 
unbearable pain and deep anxiety. The emergence of 
nanotechnology has made a significant effect on 
cancer detection and treatment. Nanotechnology has 
the ability to serve as a tool which can change the 
foundation of cancer diagnostic treatment and 
prevention. The main advantage is the small size of 
nanoparticles which helps in reaching the roots of 
cancer cells. Advanced and effective drug delivery 
systems have been designed in the past few years. 
Some of the nanoparticles used in Cancer therapy 
have unique properties like bio-compatibility which 
becomes ideal when designing effective systems.  
Nano-systems can not only cure cancer but can also 
cure damage cells and regeneration of cells. The use 
of nanoparticles can improve the harmful side effects 
of conventional techniques like chemotherapy and 
radiotherapy. The selective heat deposition to tumor 
cells is another advantage of nanotechnology which 
provides a versatile platform to cure cancer. Different 
types of cancer cells have unique properties that can 
be exploited by nanoparticles to target the cancer 
cells. In future, nano-robots could repair disease 
cells, eliminate bacterial infection in a patient without 
using treatment with antibiotics, perform surgery at 
the cellular level, remove individual disease cell and 
even repair the defective portion of defective cell. 
Nanotechnology has greater potential to save lives 
than any other method that we use today. It has 
become a boon in medical field even by delivering 
drugs to specific cells using nanoparticles. Thus, 
nanotechnology can lead to a revolution where 
thebody organs will have the ability to protect itself 
from harm and can lead a healthy life. It is a 
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technology capable of many more breakthroughs. 
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